IP Library Granted Patent US 7,015,022
Granted Patent B2
US 7,015,022 · App. 10/165,841 · Granted Mar 21, 2006

Mammalian catalase-dependent oxidation processes and methods for stimulating oxidative activities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,015,022
App. No.
10/165,841
Granted
Mar 21, 2006
Kind
B2
Abstract

A catalase-dependent enzymatic oxidation process wherein a substrate to be oxidized is contacted with catalase in the absence of hydrogen peroxide is provided. Also provided are methods for using this process in a variety of biomedical, clinical and diagnostic applications as well as industrial processes. A method for stimulating the enzymatic oxidation process by treatment with ultraviolet light and uses for this method are also provided.

Claims (7)

1. An enzymatic oxidation process wherein a selected substrate to be oxidized is contacted with mammalian catalase in the absence of hydrogen peroxide.

2. The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a fluorescent product.

3. The enzymatic oxidation process of claim 1 wherein the selected substrate is oxidized by mammalian catalase to a chemiluminescent product.

4. A screening assay for compounds that inhibit mammalian catalase comprising measuring oxidation of a selected substrate for hydrogen peroxide independent mammalian catalase activity by mammalian catalase in the presence and absence of a test compound, wherein a decrease in oxidation of the selected substrate in the presence of the test compound is indicative of the test compound inhibiting hydrogen peroxide independent mammalian catalase activity.

5. A screening assay to identity pharmacological agents activated by oxidation comprising contacting the pharmacological agent with mammalian catalase and measuring for activation of the pharmacological agent in the absence of hydrogen peroxide.

6. The screening assay of claim 5 wherein the pharmacological agent is a prodrug and activation is measured by amount of drug produced.

7. A method for accelerating oxidation of a selected substrate for hydrogen peroxide independent mammalian catalase activity by mammalian catalase comprising exposing a mixture containing the selected substrate and mammalian catalase to a low dose of ultraviolet B radiation ranging between 2.5 and 25 mJ/cm 2 at a wavelength between 290 and 320 nanometers.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Aug 13, 2014
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 033525/0369 →